Literature DB >> 507279

Value of examination for fecal leukocytes in the early diagnosis of shigellosis.

O M Korzeniowski, F A Barada, J D Rouse, R L Guerrant.   

Abstract

Fecal specimens from 101 patients with diarrhea were cultured and also examined with methylene blue for leukocytes. Thirty-six patients had leukocytes in their stools and 29 had culture-proven shigellosis. The sensitivity of fecal leukocytes in shigellosis was 95% (19/20) when cup specimens were obtained, and 44% (4/9) when swab or diaper specimens were examined. Only 45% of the patients with shigellosis who provided cup specimens had grossly bloody dysentery. Twelve other patients had fecal leukocytes but no demonstrable invasive bacterial pathogens. Methylene blue examination was useful in identifying motile trophozoites of Giardia lamblia and eggs or larvae of other heavy intestinal paraistic infections. Among patients with naturally-acquired acute diarrhea, methylene blue examination of stools for leukocytes is much more sensitive than examination for blood in predicting a positive culture for Shigella spp. It is also of value in detecting parasites.

Entities:  

Mesh:

Year:  1979        PMID: 507279     DOI: 10.4269/ajtmh.1979.28.1031

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Fecal leukocytes in Escherichia coli O157:H7 enteritis.

Authors:  N Cimolai
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

2.  Fecal lactoferrin screening assay for inflammatory bacterial diarrhea.

Authors:  I Nachamkin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

3.  Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens.

Authors:  R P Silletti; G Lee; E Ailey
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Measurement of fecal lactoferrin as a marker of fecal leukocytes.

Authors:  R L Guerrant; V Araujo; E Soares; K Kotloff; A A Lima; W H Cooper; A G Lee
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Sulfamethoxazole- trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults.

Authors:  F A Barada; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

6.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.

Authors:  S W Choi; C H Park; T M Silva; E I Zaenker; R L Guerrant
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Sulfamethoxazole-trimethoprim-resistant Shigella flexneri in northeastern Brazil.

Authors:  K M Tiemens; P L Shipley; R A Correia; D S Shields; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

8.  Fecal leukocytosis, indium-111-labelled autologous polymorphonuclear leukocyte abdominal scanning, and quantitative fecal indium-111 excretion in acute gastroenteritis and enteropathogen carriage.

Authors:  T Kordossis; A E Joseph; J N Gane; C E Bridges; G E Griffin
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

9.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.

Authors:  Cynthia L Sears; Salequl Islam; Amit Saha; Maleka Arjumand; Nur Haque Alam; A S G Faruque; M A Salam; Jai Shin; David Hecht; Andrej Weintraub; R Bradley Sack; Firdausi Qadri
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

10.  Application of rejection criteria for stool cultures for bacterial enteric pathogens.

Authors:  K Fan; A J Morris; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.